自然美(00157.HK)年度溢利升13.5%至2981萬港元
格隆匯3月25日丨自然美(00157.HK)發佈公告,截至2019年12月31日止年度,公司收入4.64億港元,同比增長25.7%;期間溢利2981萬港元,同比增長13.5%;每股盈利1.5港仙。
收益增長主要由於產品銷售額增長9910萬港元,該分部佔集團總營業額的96.4%。
公司稱,面對新冠肺炎COVID-19爆發對經濟的衝擊,東森自然美的佈局除了持續利用東森集團資源–多通路銷售平行整合能力、強大的大數據分析、線上銷售線下服務垂直整合與新媒體平台,將公司的產品推廣力道加大,讓台灣急速成長外,更加速全球的佈局,特別是東南亞市場的投資與發展,增闢多市場的營收,除了減低中國大陸受疫情衝擊對營收的影響外,更讓東森自然美成為名符其實的國際馳名美容品牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.